世界のコネクテッド薬物送達デバイス市場2021年-2030年:種類別(注射器、吸入器)、技術別、エンドユーザー別

【英語タイトル】Connected Drug Delivery Devices Market By Type (Injectable, Inhalation Devices), By Technology (Bluetooth, NFC, Others), By End-use (Homecare, Hospitals): Global Opportunity Analysis and Industry Forecast, 2021-2030

Allied Market Researchが出版した調査資料(ALD22NV0015)・商品コード:ALD22NV0015
・発行会社(調査会社):Allied Market Research
・発行日:2022年8月
・ページ数:210
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,730 ⇒換算¥848,040見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥954,600見積依頼/購入/質問フォーム
Enterprise UserUSD9,600 ⇒換算¥1,420,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社の本調査資料では、世界のコネクテッド薬物送達デバイス市場規模が2021年290.3百万ドルから2030年2,095.2百万ドルに達し、2022年から2030年まで年平均24.29%成長すると予測しています。当書は、コネクテッド薬物送達デバイスの世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、種類別(注射器、吸入器)分析、技術別(Bluetooth、NFC、その他)分析、エンドユーザー別(在宅医療、病院)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ)分析、企業状況などについて以下の構成でまとめております。なお、参入企業情報として、Adherium、BD、Proteus Digital Health、PROPELLER HEALTH、F. Hoffmann-La Roche Ltd、Ypsomed AG、Cohero Health, Inc.、West Pharmaceutical Services, Inc.、Syncro Technology Corp.、AptarGroup Inc.などが含まれております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界のコネクテッド薬物送達デバイス市場規模:種類別
- 注射器の市場規模
- 吸入器の市場規模
・世界のコネクテッド薬物送達デバイス市場規模:技術別
- Bluetoothデバイスの市場規模
- NFCデバイスの市場規模
- その他技術の市場規模
・世界のコネクテッド薬物送達デバイス市場規模:エンドユーザー別
- 在宅医療における市場規模
- 病院における市場規模
・世界のコネクテッド薬物送達デバイス市場規模:地域別
- 北米のコネクテッド薬物送達デバイス市場規模
- ヨーロッパのコネクテッド薬物送達デバイス市場規模
- アジア太平洋のコネクテッド薬物送達デバイス市場規模
- 中南米・中東・アフリカのコネクテッド薬物送達デバイス市場規模
・企業状況
・企業情報

The global connected drug delivery devices market is envisioned to garner $2,095.2 million by 2030, growing from $290.3 million in 2021 at a CAGR of 24.29% from 2022 to 2030.
Connected drug delivery devices are integrated with capabilities that include connectivity to a wide range of digital services. These devices are being developed by various market players with an aim to support superior patient supervision and counselling. Connected drug delivery devices are equipped with several features, such as adherence trackers, dosing remainders, and patient diaries to collect health information. These devices are prominently used in the treatment of asthma, Chronic Obstructive Pulmonary Disease (COPD), diabetes, and other cardiovascular disorders.
The efficiency of drug delivery devices in therapeutic procedures along with rising usage of electronic healthcare devices are anticipated to fuel market expansion for connected drug delivery devices over the forecast period. In addition to this, it is projected that an increase in the prevalence of diabetes, COPD, and asthma will offer a lucrative potential for increasing use of connected drug delivery devices throughout the course of the forecast period.
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, and imposition of stringent regulations on drug delivery systems are expected to hinder the market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, availability of low-cost substitutes, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period.
Furthermore, increased public-private funding for targeted research initiatives, rising air pollution levels, and an increase in product innovations and development due to global technological breakthroughs will all create lucrative opportunities for key players in the market throughout the projection period. In the future, the market growth rate will be accelerated due to expanding number of strategic alliances, increasing Internet usage, increasing number of hospitals and laboratories, and rising per-capita expenditure on health care spending. For instance, in February 2022, Aptar Pharma, a global leader in drug delivery systems launched a product Hero Tracker Sense, which is a next generation Metered-Dose Inhaler (MDI) add-on connected device, designed to address patient inhalation technique and adherence. It is designed to help improve the lives of patients around the world suffering from chronic respiratory diseases such as asthma, COPD, cystic fibrosis, and other respiratory conditions caused by COVID-19, to track their MDI usage and facilitate improved adherence to their prescribed therapy.
Global distribution and sales channel disruption due to COVID-19 pandemic could be blamed for the decline in connected drug delivery devices sales. People had to face restrictions such as lockdown, social distancing, and others. During the pandemic, business processes such as production, inventory management, and distribution of goods and services have ceased, which is expected to have a significant impact on the worldwide economy. However, the coronavirus outbreak made the high demand for simple and secure homecare setting medical devices. A healthcare provider is now able to remotely monitor a patient’s medicine due to the requirement for online connectivity equipment. Owing to these factors, the COVID-19 pandemic’s negative effects were decreased and the market kept expanding gradually.
The key players profiled in the connected drug delivery devices market report include Adherium, BD, Proteus Digital Health, propeller Health, F. Hoffmann-La Roche Ltd, Ypsomed AG, Cohero Health, Inc., West Pharmaceutical Services, Syncro Technology Corp., and AptarGroup Inc.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the connected drug delivery devices market analysis from 2021 to 2030 to identify the prevailing connected drug delivery devices market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the connected drug delivery devices market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global connected drug delivery devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type
● Injectable
● Inhalation Devices

By Technology
● Bluetooth
● NFC
● Others

By End-use
● Homecare
● Hospitals

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ United Kingdom
○ France
○ Spain
○ Italy
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest Of Asia Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ UAE
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ Adherium
○ BD
○ Proteus Digital Health
○ PROPELLER HEALTH
○ F. Hoffmann-La Roche Ltd
○ Ypsomed AG
○ Cohero Health, Inc.
○ West Pharmaceutical Services, Inc.
○ Syncro Technology Corp.
○ AptarGroup Inc.

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Regulatory Guidelines
3.8.Value Chain Analysis
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Injectable
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Inhalation Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Bluetooth
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 NFC
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE
6.1 Overview
6.1.1 Market size and forecast
6.2 Homecare
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Technology
7.2.4 North America Market size and forecast, by End-use
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Technology
7.2.5.1.3 Market size and forecast, by End-use
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Technology
7.2.5.2.3 Market size and forecast, by End-use
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Technology
7.2.5.3.3 Market size and forecast, by End-use
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End-use
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Technology
7.3.5.1.3 Market size and forecast, by End-use
7.3.5.2 United Kingdom
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Technology
7.3.5.2.3 Market size and forecast, by End-use
7.3.5.3 France
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Technology
7.3.5.3.3 Market size and forecast, by End-use
7.3.5.4 Spain
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Technology
7.3.5.4.3 Market size and forecast, by End-use
7.3.5.5 Italy
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Technology
7.3.5.5.3 Market size and forecast, by End-use
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Technology
7.3.5.6.3 Market size and forecast, by End-use
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Technology
7.4.4 Asia-Pacific Market size and forecast, by End-use
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Technology
7.4.5.1.3 Market size and forecast, by End-use
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Technology
7.4.5.2.3 Market size and forecast, by End-use
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Technology
7.4.5.3.3 Market size and forecast, by End-use
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Technology
7.4.5.4.3 Market size and forecast, by End-use
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Technology
7.4.5.5.3 Market size and forecast, by End-use
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Technology
7.4.5.6.3 Market size and forecast, by End-use
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Technology
7.5.4 LAMEA Market size and forecast, by End-use
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Technology
7.5.5.1.3 Market size and forecast, by End-use
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Technology
7.5.5.2.3 Market size and forecast, by End-use
7.5.5.3 UAE
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Technology
7.5.5.3.3 Market size and forecast, by End-use
7.5.5.4 South Africa
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Technology
7.5.5.4.3 Market size and forecast, by End-use
7.5.5.5 Rest of LAMEA
7.5.5.5.1 Market size and forecast, by Type
7.5.5.5.2 Market size and forecast, by Technology
7.5.5.5.3 Market size and forecast, by End-use
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Adherium
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 BD
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Proteus Digital Health
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 PROPELLER HEALTH
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 F. Hoffmann-La Roche Ltd
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Ypsomed AG
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Cohero Health, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 West Pharmaceutical Services, Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Syncro Technology Corp.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 AptarGroup Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments



★調査レポート[世界のコネクテッド薬物送達デバイス市場2021年-2030年:種類別(注射器、吸入器)、技術別、エンドユーザー別] (コード:ALD22NV0015)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のコネクテッド薬物送達デバイス市場2021年-2030年:種類別(注射器、吸入器)、技術別、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆